1,2,3,4-Tetrahydro-benzo[b]azepin-5-one | CAS:1127-74-8

We serve 1,2,3,4-Tetrahydro-benzo[b]azepin-5-one CAS:1127-74-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1,2,3,4-Tetrahydro-benzo[b]azepin-5-one

Chemical Name:1,2,3,4-Tetrahydro-benzo[b]azepin-5-one
CAS.NO:1127-74-8
Synonyms:1,2,3,4-Tetrahydro-benzo[b]azepin-5-one
1,2,3,4-Tetrahydro-5H-1-benzazepin-5-one
1,2,3,4-Tetrahydrobenzo[b]azepin-5-one
1,2,3,4-Tetrahydrobenzazepine-5-one
1,2,3,4-tetrahydro-1-benzazepin-5-one
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 314.6±12.0 °C at 760 mmHg
Melting Point 87-88°C
Molecular Formula C10H11NO
Molecular Weight 161.200
Vapour Pressure 0.0±0.7 mmHg at 25°C
Index of Refraction 1.548
 
Specification:
Appearance:Yellow to dark green powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Conivaptan hydrochloride(CAS:168626-94-6).



Contact us for information like 1,2,3,4-Tetrahydro-benzo[b]azepin-5-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,2,3,4-tetrahydro-1-benzazepin-5-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2,3,4-tetrahydro-1-benzazepin-5-one Use and application,1,2,3,4-Tetrahydro-benzo[b]azepin-5-one technical grade,usp/ep/jp grade.


Related News: As you can see, a considerable number of staff is involved in the production phase until an API is finally manufactured.6-Chloro-2-hexanone manufacturer The patient, who arrived from Wuhan, is “stable and under medical care,” the ministry said in a statement, adding there is “no cause for concern” for the public.methyl 2-(isocyanatosulfonylmethyl)benzoate supplier The patient, who arrived from Wuhan, is “stable and under medical care,” the ministry said in a statement, adding there is “no cause for concern” for the public.cytosine vendor China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.The videos have gone viral on Chinese social media and have been praised as a novel way to raise awareness of the disease.